ASX - By Stock
|
HIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Hornacek
|
12 |
3.3K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
12
|
3.3K
|
2
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Hornacek
|
12 |
3.3K |
1 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
12
|
3.3K
|
1
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Hornacek
|
12 |
3.3K |
2 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
12
|
3.3K
|
2
|
|
ASX - By Stock
|
MKL |
Re:
Ann: Capital Raise to Drive Original IP and Co-Development Growth
|
|
Hornacek
|
6 |
3.1K |
4 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
6
|
3.1K
|
4
|
|
ASX - By Stock
|
MKL |
Re:
Ann: Capital Raise to Drive Original IP and Co-Development Growth
|
|
Hornacek
|
6 |
3.1K |
1 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
6
|
3.1K
|
1
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Hornacek
|
8 |
2.1K |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
8
|
2.1K
|
0
|
|
ASX - By Stock
|
OVN |
Re:
Ann: Quarterly Business Review & App 4C
|
|
Hornacek
|
10 |
2.2K |
1 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
10
|
2.2K
|
1
|
|
ASX - By Stock
|
OVN |
Re:
Ann: Quarterly Business Review & App 4C
|
|
Hornacek
|
10 |
2.2K |
1 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
10
|
2.2K
|
1
|
|
ASX - By Stock
|
BUB |
Re:
Ann: FY21 Q4 - Activity Report and Appendix 4C Cashflow Statement
|
|
Hornacek
|
55 |
38K |
5 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
55
|
38K
|
5
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Hornacek
|
1 |
742 |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
1
|
742
|
0
|
|
ASX - By Stock
|
BUB |
Re:
Ann: FY21 Q4 - Activity Report and Appendix 4C Cashflow Statement
|
|
Hornacek
|
55 |
38K |
1 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
55
|
38K
|
1
|
|
ASX - By Stock
|
BUB |
Re:
Ann: FY21 Q4 - Activity Report and Appendix 4C Cashflow Statement
|
|
Hornacek
|
55 |
38K |
3 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
55
|
38K
|
3
|
|
ASX - By Stock
|
BUB |
Re:
Ann: FY21 Q4 - Activity Report and Appendix 4C Cashflow Statement
|
|
Hornacek
|
55 |
38K |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
55
|
38K
|
0
|
|
ASX - By Stock
|
ART |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Hornacek
|
5 |
2.3K |
2 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
5
|
2.3K
|
2
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Bupa Dental Trials HITIQ Technology with Junior Rugby
|
|
Hornacek
|
5 |
3.4K |
0 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
5
|
3.4K
|
0
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Bupa Dental Trials HITIQ Technology with Junior Rugby
|
|
Hornacek
|
5 |
3.4K |
0 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
5
|
3.4K
|
0
|
|
ASX - By Stock
|
ART |
Re:
C level redunancy
|
|
Hornacek
|
6 |
4.1K |
1 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
6
|
4.1K
|
1
|
|
ASX - By Stock
|
ART |
Re:
C level redunancy
|
|
Hornacek
|
6 |
4.1K |
0 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
6
|
4.1K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
What's going on with Race Oncology at the moment ?
|
|
Hornacek
|
146 |
47K |
4 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
146
|
47K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
What's going on with Race Oncology at the moment ?
|
|
Hornacek
|
146 |
47K |
7 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
146
|
47K
|
7
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Top 20 Shareholders
|
|
Hornacek
|
43 |
22K |
0 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
43
|
22K
|
0
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Top 20 Shareholders
|
|
Hornacek
|
43 |
22K |
0 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
43
|
22K
|
0
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Top 20 Shareholders
|
|
Hornacek
|
43 |
22K |
0 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
43
|
22K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Appendix 4C - quarterly
|
|
Hornacek
|
21 |
4.9K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
21
|
4.9K
|
2
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Appendix 4C - quarterly
|
|
Hornacek
|
21 |
4.9K |
3 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
21
|
4.9K
|
3
|
|
ASX - By Stock
|
OVN |
Re:
Ann: Quarterly Business Review & Appendix 4C
|
|
Hornacek
|
15 |
4.2K |
1 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
15
|
4.2K
|
1
|
|
ASX - By Stock
|
MPA |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
Hornacek
|
2 |
2.1K |
5 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
2
|
2.1K
|
5
|
|
ASX - By Stock
|
HLF |
Re:
Ann: FY21 Revenue Announcement
|
|
Hornacek
|
145 |
38K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
145
|
38K
|
1
|
|
ASX - By Stock
|
MPA |
Re:
IPO - Mad Paws Holdings Limited - 26 March 2021 #
|
|
Hornacek
|
43 |
31K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
43
|
31K
|
1
|
|
ASX - By Stock
|
HLF |
Re:
Ann: FY21 Revenue Announcement
|
|
Hornacek
|
145 |
38K |
2 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
145
|
38K
|
2
|
|
ASX - By Stock
|
HLF |
Re:
Ann: FY21 Revenue Announcement
|
|
Hornacek
|
145 |
38K |
5 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
145
|
38K
|
5
|
|
ASX - By Stock
|
MKT |
Re:
Sleeping Giant
|
|
Hornacek
|
24 |
9.6K |
1 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
24
|
9.6K
|
1
|
|
ASX - By Stock
|
MKT |
Re:
Sleeping Giant
|
|
Hornacek
|
24 |
9.6K |
0 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
24
|
9.6K
|
0
|
|
ASX - By Stock
|
MKT |
Sleeping Giant
|
|
Hornacek
|
24 |
9.6K |
3 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
24
|
9.6K
|
3
|
|
ASX - By Stock
|
MPA |
Re:
IPO - Mad Paws Holdings Limited - 26 March 2021 #
|
|
Hornacek
|
43 |
31K |
2 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
43
|
31K
|
2
|
|
ASX - By Stock
|
MPA |
Re:
IPO - Mad Paws Holdings Limited - 26 March 2021 #
|
|
Hornacek
|
43 |
31K |
2 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
43
|
31K
|
2
|
|
ASX - By Stock
|
MPA |
Re:
IPO - Mad Paws Holdings Limited - 26 March 2021 #
|
|
Hornacek
|
43 |
31K |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
43
|
31K
|
0
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Change of Director's Interest Notice - MJ
|
|
Hornacek
|
7 |
2.4K |
2 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
7
|
2.4K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Hornacek
|
179 |
58K |
3 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
179
|
58K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
Hornacek
|
114 |
32K |
2 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
114
|
32K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
Hornacek
|
114 |
32K |
1 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
114
|
32K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Hornacek
|
11K |
3.8M |
4 |
22/03/21 |
22/03/21 |
General
|
11K
|
3.8M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Hornacek
|
179 |
58K |
2 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
179
|
58K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Hornacek
|
11K |
3.8M |
10 |
22/03/21 |
22/03/21 |
General
|
11K
|
3.8M
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Hornacek
|
11K |
3.8M |
3 |
22/03/21 |
22/03/21 |
General
|
11K
|
3.8M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Hornacek
|
11K |
3.8M |
9 |
22/03/21 |
22/03/21 |
General
|
11K
|
3.8M
|
9
|
|
ASX - By Stock
|
RNO |
Re:
Ann: Change of Director's Interest Notice - MJ
|
|
Hornacek
|
7 |
2.4K |
0 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Hornacek
|
179 |
58K |
3 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
179
|
58K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Hornacek
|
179 |
58K |
8 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
179
|
58K
|
8
|
|
ASX - By Stock
|
OVN |
Re:
Ann: Investor Briefing
|
|
Hornacek
|
5 |
2.4K |
5 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
5
|
2.4K
|
5
|
|